Building a Platform Biotech and The Future of R&D: In Conversation With Chris Gibson

I sat down with Chris Gibson, co-founder and CEO of Recursion, for part two of a series following up on a few pieces I wrote on pharma software and data including Real World Evidence and R&D tools. Chris and Recursion are at the forefront of using AI for drug discovery. We discussed how Recursion predicted drugs that would be effective for COVID, his take on different techbio business models, and…

See it on vitalsignshealth.substack.com ↗